Analytical Data
-
Gene name
GPR107
- Application
-
Alternative Names
(Lung seven transmembrane receptor 1)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5VW38
-
Expression Region
40-263aa
-
Molecular Weight
32.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPR107 is an orphan G protein-coupled receptor (GPCR) that has garnered interest in recent years due to its potential roles in various physiological processes and disease states. As a member of the GPCR superfamily, GPR107 is characterized by its unique structure, which includes seven transmembrane domains, a hallmark of GPCRs that facilitates signal transduction across cell membranes. The receptor is known to be involved in cellular responses to ligands, but its exact physiological function remains largely elusive, leading to a growing demand for research to elucidate its role in human health and disease. Emerging studies suggest that GPR107 may play a part in tumor biology, neurobiology, and metabolic processes, making it a candidate for therapeutic targeting in a range of conditions such as cancer and neurodegenerative diseases. Given the complexity of GPCR signaling and the potential implications of GPR107 in pathological conditions, the production of recombinant GPR107 protein is essential for functional assays, structural studies, and drug discovery efforts. Understanding the receptor's ligand-binding properties and downstream signaling pathways through the use of its recombinant form will enhance our knowledge of GPR107's role in cellular communication and open new avenues for developing targeted therapies. Advances in recombinant protein technology enable the generation of purified GPR107 for high-throughput screening and structural analysis, ultimately contributing to the broader field of GPCR research and personalized medicine.
